Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
11.02
-0.75 (-6.37%)
At close: Nov 5, 2026, 4:00 PM EST
11.43
+0.41 (3.72%)
After-hours: Nov 5, 2026, 7:30 PM EST

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $-188.00K in the quarter ending September 30, 2026. This brings the company's total for the last twelve months to $302.80M, up 1,695.96% year-over-year. In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%. That makes Vir Biotechnology the 14,484th largest company in the world by revenue and 2,603rd in the United States.

Revenue (ttm)
$302.80M
Revenue Growth
+1,695.96%
P/S Ratio
6.16
Revenue / Employee
$825,065
Employees
367
Market Cap
1.86B

Revenue Chart

Revenue by Geography

  • Foreign 66.52M 97.0%
  • United States 2.04M 3.0%
Fiscal year ended Dec 31, 2025 See the full Vir Biotechnology breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.